
Search Clinical Trials
Study is registered in ResearchMatch ![]() Sponsor Condition of Interest |
|---|
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
National Institute of Allergy and Infectious Diseases (NIAID)
Alpha and Beta Thalassemia
Sickle Cell Disease
Malaria
Human Physiology
Background:
Blood disorders like sickle cell disease and malaria affect many people around the world.
Researchers want to learn more about blood disorders. To do this, they need to collect
biological samples from people with blood disorders. They also need to collect samples
from healthy people.1 expand
Background: Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need to collect biological samples from people with blood disorders. They also need to collect samples from healthy people. Objective: To collect samples to use for research on blood disorders. Eligibility: People ages 18-70 who have blood disorders. Healthy volunteers without blood disorders are also needed. Design: Participants will be screened with a medical history, physical exam, and blood and urine tests. Participants will give one or more samples. They will give them over 5 years. They can choose not to give any of the samples: Saliva: Participants will spit into a tube. They may also have the inside of their mouth swabbed. Urine: Participants will urinate into a cup. Blood and blood waste products: Blood will be taken through a needle in the participant s arm. Fat samples: An area on the participant s belly or buttock will be numbed. A small cut will be made into the skin and a small piece of fat removed. Mucus and cells from the lungs: The participant will be sedated. A flexible tube will be inserted through the nose or mouth into the lung airways. These participants will also have a physical exam, chest x-ray, and heart tests after the procedure. Type: Observational Start Date: Sep 2019 |
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have1
National Institute of Allergy and Infectious Diseases (NIAID)
Herpes Zoster
Background:
Shingles is a painful, blistering rash caused by the same virus that causes chickenpox.
Shingrix is a vaccine approved to prevent shingles in healthy adults over age 50 and in
immunocompromised adults over age 18. Researchers want to learn more about how people
with HIV respond to Shin1 expand
Background: Shingles is a painful, blistering rash caused by the same virus that causes chickenpox. Shingrix is a vaccine approved to prevent shingles in healthy adults over age 50 and in immunocompromised adults over age 18. Researchers want to learn more about how people with HIV respond to Shingrix. Objective: To learn how Shingrix affects the immune response in people with HIV. Eligibility: People aged 18 years and older with HIV. Healthy people aged 50 years or older are also needed. Design: Participants will have at least 4 clinic visits in 1 year. Participants will be screened. They will have a physical exam with blood and urine tests. At their first visit, participants will receive Shingrix as a shot in the upper arm. They will have a rectal swab; a cotton swab will be inserted into the rectum and rotated gently to collect bacteria. Participants will receive a second shot of Shingrix 2 months after the first one. They will visit the clinic again 3 and 12 months after the first shot. Participants will receive a 28-day memory tool. They will write down their symptoms between clinic visits. They will have up to 4 phone calls to talk about side effects of the shot. Participants may undergo apheresis: They will lie still while blood is drawn from a needle in one arm. The blood will pass through a machine that separates out the white blood cells. The remaining blood will be given back through a second needle in their other arm. Type: Interventional Start Date: Mar 2023 |
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Earl1
Memorial Sloan Kettering Cancer Center
Early Stage Breast Cancer
This study will compare the effects on cardiorespiratory fitness (CRF) of aerobic
exercise in different amounts (number of minutes/session) over different periods of time
(number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity
that uses the large muscle groups (muscl1 expand
This study will compare the effects on cardiorespiratory fitness (CRF) of aerobic exercise in different amounts (number of minutes/session) over different periods of time (number of weeks). Aerobic exercise is physical activity of light-to-moderate intensity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for at least 10 minutes. The researchers will study the effects of different exercise programs on how well the study participants' bodies use oxygen, how well their heart pumps blood, how well their lungs function, and how healthy their blood vessels are. Type: Interventional Start Date: Oct 2020 |

